Globus Medical (GMED)
(Real Time Quote from BATS)
$74.85 USD
-0.03 (-0.04%)
Updated Nov 4, 2024 03:28 PM ET
2-Buy of 5 2
C Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GMED 74.85 -0.03(-0.04%)
Will GMED be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Insulet Stock Gains From Expansion Strategies, Innovation
QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain DGX Stock in Your Portfolio Now
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
Boston Scientific Stock Gains From Market Expansion, Innovation
Other News for GMED
Paradice Investment Management LLC Increases Stake in Skillsoft Corp
Globus Medical Inc (GMED) Shares Up 3.6% on Oct 15
Globus Medical (GMED) Receives a Buy from Stifel Nicolaus
Globus Medical price target raised by $1 at BTIG, here's why
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts